Publicación

Changes in plasma adipokines in prepubertal children with a history of extrauterine growth restriction

  • NUTRITION
  • Autores
    Ortiz-Espejo, M; Perez-Navero, JL; Olza, J; Munoz-Villanueva, MC; Aguilera, CM; Gil-Campos, M
  • Año Publicación
    2013
  • Volumen
    29
  • Número
    11-Dec
  • Pág. Inicio
    1321
  • Pág. Fin
    1325
  • Pág. Fin
    1321
Referencia Citadas
34
Citas Web of Science
5
Total de veces citado (Z9)
5
Recuento Uso 5 años
9

Objective: Because nutritional support in perinatal life has been associated with metabolic programming, children with a history of extrauterine growth restriction (EUGR) might display alterations in the adipocyte and in the secretion of adipokines. The aim of this study was to assess adiponectin, resistin, and leptin concentrations in prepubertal children with a history of EUGR, and to determine the potential correlation between these adipokines and metabolic parameters. Methods: This case-control study sample included 38 prepubertal children with a history of EUGR and a control group of 123 healthy children of similar age and sex. Anthropometric measures and blood pressure were assessed. Biochemical markers and blood adipokine concentrations (adiponectin, resistin, and leptin) were evaluated. Results: Adiponectin concentration was significantly lower in the EUGR group compared with controls (EUGR: 11.49 +/- 6.07 versus control: 25.72 +/- 10.13 mu g/mL), and resistin concentration was higher (EUGR: 20332.95 +/- 6401.25 versus control: 8056.31 +/- 3823.63 pg/mL), even after adjustment for gestational age, weight, and size at birth. Systolic blood pressure was associated with adipokines concentrations in the EUGR group (P < 0.001). In EUGR children adiponectin was associated with high-density lipoprotein cholesterol (P = 0.042), whereas resistin was associated with carbohydrate metabolism parameters (P < 0.001). Conclusions: Early postnatal malnutrition in EUGR children could program adipose tissue. Plasma adipokines can be measured in childhood to identify precocious changes that may be associated with a higher risk for metabolic syndrome or cardiovascular disease later in life. (C) 2013 Elsevier Inc. All rights reserved.


Web financiada por la Junta de Andalucía, Consejería de Conocimiento, Investigación y Universidades, Fondo Europeo de Desarrollo Regional (FEDER), proyecto SOMM17/6107/UG

Web financiada por la Junta de Andalucía, Consejería de Conocimiento, Investigación y Universidades, Fondo Europeo de Desarrollo Regional (FEDER), proyecto SOMM17/6107/UGR